Skip to search formSkip to main contentSkip to account menu

Somatuline

National Institutes of Health

Related topics

Related topics

7 relations
0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline]0.5 ML lanreotide 240 MG/ML Prefilled Syringe [Somatuline]flutamide/leuprolide/somatuline/suraminsomatuline/suramin

Broader (3)

OctreotideSandostatinlanreotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Le défi d’une acromégalie avec IRM hypophysaire normale
2016
2016
Une tumeur hypophysaire FSH-ACTH agressive
2014
2014
Traitement médical primaire des adénomes thyréotropes par les analogues de la somatostatine : à propos de 7 cas
2014
2014
AVCI transitoire : mode de révélation inhabituel d’une acromégalie
2012
2012
Evaluation of safety and efficacy of somatuline autogel in combination with molecular targeted therapies (MTT) in patients with neuroendocrine tumors (NETs): Data from one Spanish cohort.
e14671 Background: Analysis of the mechanisms of action of somatostatin analogs (SSAs) and mTOR inhibitors or tyrosine kinase… 
1999
1999
An open, phase III study of lanreotide (Somatuline PR) in the treatment of acromegaly.
Acromegaly is a disorder caused by excessive secretion of human growth hormone (GH). Somatostatin and its analogue-prolonged… 
1995
1995
Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum
Radioligand binding studies were performed in membranes of rat cerebellum using [125I]-[Tyr3]octreotide ([125I]204-090) to… 
Review
1994
Review
1994
[Treatment of acromegaly with a new slow release somatostatin analog, lanreotide].
Treatment of Acromegaly has been improved by the development of the somatostatin analogs characterized by an increased… 
1993
1993
Somatostatin binding in human gastrointestinal tissues: effect of cations and somatostatin analogues.
This study characterises the somatostatin binding site in human gastrointestinal cancer and mucosa in terms of cationic… 
1993
1993
Somatostatin analogue (somatuline) in hormone resistant prostate cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)